Latest News & Features
Big Pharma
Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices. 23 February 2023
Biotechnology
Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19. 21 February 2023
Big Pharma
Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca| Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson. 21 February 2023
Big Pharma
The long-running legal saga between the pharma giant and the NHS as well as generic drug makers has developed further, as Darren Smyth of EIP explains. 15 February 2023
article
The move is part of a strategic plan, with a focus on patents. 15 February 2023
Americas
The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity. 15 February 2023
Americas
Dietary supplements containing a form of vitamin B3 found in cow’s milk are unpatentable | Judge cites Myriad noting that the “act of isolating the NR compared to how NR naturally exists in milk is not sufficient, on its own, to confer patent eligibility”. 14 February 2023
Americas
J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”. 13 February 2023
Americas
Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid. 9 February 2023
Asia
The Tokyo District Court judgment on patent infringement and question of territoriality is game-changing, says Takanori Abe of Abe & Partners. 9 February 2023